← Back to BCDA

BioCardia, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0$0$0$0$0$0.1
−$1.6−$2.3−$1.5−$2−$2.7−$1.7−$1.6−$2.3
−$0.13−$0.21−$0.24−$0.40−$0.59−$0.61−$0.88−$1.35
12116.35.14.62.81.91.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.